A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

Pfeffer, Marc A., Burdmann, Emmanuel A., Chen, Chao-Yin, Cooper, Mark E., de Zeeuw, Dick, Eckardt, Kai-Uwe, Feyzi, Jan M., Ivanovich, Peter +11 more·2009·New England Journal of Medicine

DOI 10.1056/nejmoa0907845

Cited by (1,000)

Items 201–300 of 1,000

Recommendations by the Asian Pacific society of nephrology ( APSN ) on the appropriate use of HIF‐PH inhibitors
Desmond Y. H. Yap, Lawrence P. McMahon, Chuan‐Ming Hao, Nan Hu, Hirokazu Okada, Yusuke Suzuki, Sung Gyun Kim, Soo Kun Lim, Kriengsak Vareesangthip, Chi‐Chih Hung et al. · 2020 · Nephrology
Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations
Jonathan P. Law, Luke C. Pickup, Davor Pavlović, John Townend, Charles Joseph Ferro · 2022 · Journal of Human Hypertension
Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
Joshua Kaplan, Neeraj Sharma, Sean J. Dikdan · 2018 · International Journal of Molecular Sciences
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
George R. Bailie, Maria Larkina, David A. Goodkin, Y. Li, R.L. Pisoni, Brian A. Bieber, N. Mason, L. Tong, Francesco Locatelli, Mark Roger Marshall et al. · 2013 · Nephrology Dialysis Transplantation
Optimal Care of the Infant, Child, and Adolescent on Dialysis: 2014 Update
Bradley A. Warady, Alicia M. Neu, Franz S. Schaefer · 2014 · American Journal of Kidney Diseases
Early detection of CKD: the benefits, limitations and effects on prognosis
Adeera Levin, Paul E. Stevens · 2011 · Nature Reviews Nephrology
Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia
Daniel Eriksson, David J.A. Goldsmith, S Teitsson, James Jackson, Floortje E. van Nooten · 2016 · BMC Nephrology
Efficacy and safety of erythropoietin and iron therapy to reduce red blood cell transfusion in surgical patients: a systematic review and meta-analysis
Tiffanie Kei, Nikhil Mistry, Gerard F. Curley, Katerina Pavenski, Nadine Shehata, Rosa Maria Tanzini, Marie-France Gauthier, Kevin E. Thorpe, Tom A. Schweizer, Sarah E Ward et al. · 2019 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
Post-Transplant Cardiovascular Disease
Kelly A. Birdwell, Meyeon Park · 2021 · Clinical Journal of the American Society of Nephrology
Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial
Kunitoshi Iseki, H. Arima, Kentaro Kohagura, Ichiro Komiya, Shinichiro Ueda, K. Tokuyama, Yoshiki Shiohira, Hitoshi Uehara, Shigeki Toma, N. Tomiyama et al. · 2013 · Nephrology Dialysis Transplantation
Defining end-stage renal disease in clinical trials: a framework for adjudication: Table 1.
Rajiv Agarwal · 2015 · Nephrology Dialysis Transplantation
Anemia of chronic disease: A unique defect of iron recycling for many different chronic diseases
Erika Poggiali, Margherita Migone De Amicis, Irene Motta · 2013 · European Journal of Internal Medicine
A novel approach to adenine-induced chronic kidney disease associated anemia in rodents
Asadur Rahman, Daisuke Yamazaki, Abu Sufiun, Kento Kitada, Hirofumi Hitomi, Daisuke Nakano, Akira Nishiyama · 2018 · PLoS ONE
Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
Kirsten L. Johansen, Fredric O. Finkelstein, Dennis A. Revicki, Chris Evans, Shaowei Wan, Matthew D. Gitlin, Irene Agodoa · 2011 · Nephrology Dialysis Transplantation
Low Hemoglobin Concentrations Are Associated With Sarcopenia, Physical Performance, and Disability in Older Australian Men in Cross-sectional and Longitudinal Analysis: The Concord Health and Ageing in Men Project
Vasant Hirani, Vasi Naganathan, Fiona Blyth, David George Le Couteur, Markus J. Seibel, Louise M. Waite, David J. Handelsman, Benjumin Hsu, Robert Graham Cumming · 2016 · The Journals of Gerontology Series A
Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents
Matthew R. Weir · 2021 · American Journal of Nephrology
Mortality Rates in Trials of Subjects With Type 2 Diabetes
Ebrahim Barkoudah, Hicham Skali, Hajime Uno, Scott David Solomon, Marc Alan Pfeffer · 2012 · Journal of the American Heart Association
Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study
Alberto Martínez‐Castelao, José Luis Górriz, José María Portolés, Fernando de Álvaro, Aleix Cases, José Luño, Juan F. Navarro‐González, Rafael Montes, Juan J. de la Cruz, Aparna Natarajan et al. · 2011 · BMC Nephrology
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Marcello A. Tonelli, J B Berns, Biykem Bozkurt, Rebecca Cheung, Yarieli Cuevas, Emmanuel E. Effa, Michele Freerk Eisenga, Steven Fishbane, Yelena Z. Ginzburg, Volker H. Haase et al. · 2026 · Kidney International
Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON)
Dick de Zeeuw, Tadao Akizawa, Rajiv Agarwal, Paul Audhya, George L. Bakris, Melanie P. Chin, Melissa Krauth, Hiddo J.L. Heerspink, Colin J. Meyer, John J.V. McMurray et al. · 2013 · American Journal of Nephrology
The Association Between Perioperative Hemoglobin and Acute Kidney Injury in Patients Having Noncardiac Surgery
Michael W. Walsh, Amit X. Garg, Philip James Devereaux, Maged Y. ARGALIOUS, Hooman Honar, Daniel I. Sessler · 2013 · Anesthesia & Analgesia
Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD
Robert Provenzano, Lynda Anne M. Szczech, Robert Leong, Khalil G. Saikali, Ming Zhong, Tyson T. Lee, Dustin J. Little, Mark T. Houser, Lars Frison, John Houghton et al. · 2021 · Clinical Journal of the American Society of Nephrology
Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy
Aliza Thompson, Daniel Cattran, Melanie J. Blank, Patrick H. Nachman · 2015 · Journal of the American Society of Nephrology
Physiological and pathophysiological mechanisms of hepcidin regulation: clinical implications for iron disorders
Yang Xu, Víctor Manuel Alfaro-Magallanes, Jodie L. Babitt · 2020 · British Journal of Haematology
Is anemia a new cardiovascular risk factor?
Kaiafa, Georgia, Kanellos, Ilias, Savopoulos, Christos, Kakaletsis, Nikolaos, Giannakoulas, George, Hatzitolios, Apostolos I. · 2015 · International Journal of Cardiology
The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial
Daniel W. Coyne · 2012 · Kidney International
Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa
Hicham Skali, Hans‐Henrik Parving, Patrick S. Parfrey, Emmanuel A. Burdmann, Eldrin Foster Lewis, Peter T. Ivanovich, Sai Ram Keithi-Reddy, Janet B. McGill, John J.V. McMurray, Ajay K. Singh et al. · 2011 · Circulation
Biosimilar epoetins and other “follow‐on” biologics: Update on the European experiences
WOLFGANG E. B. JELKMANN · 2010 · American Journal of Hematology
Cerebrovascular Disease and Cognition in Chronic Kidney Disease Patients
Marius Miglinas, Ugne Cesniene, Marta Monika Janusaite, Artūras Vinikovas · 2020 · Frontiers in Cardiovascular Medicine
Red Blood Cell Transfusions and the Risk of Allosensitization in Patients Awaiting Primary Kidney Transplantation
Mary Sue Leffell, Deborah Kim, Renato M. Vega, Andrea A. Zachary, Jeffrey Petersen, John M. Hart, Jérôme Rossert, Brian D. Bradbury · 2013 · Transplantation
Sensitization from transfusion in patients awaiting primary kidney transplant
Julie M. Yabu, Matthew W. Anderson, D. Kim, Brian D. Bradbury, Chengli Lou, Jeffrey Petersen, Jérôme Rossert, Glenn Matthew Chertow, Dolly B. Tyan · 2013 · Nephrology Dialysis Transplantation
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics
Roberto Minutolo, Francesco Locatelli, Maurizio Alberto Gallieni, Renzo Bonofiglio, Giorgio Fuíano, Lamberto Oldrizzi, Giuseppe Conte, Luca De Nicola, Filippo Mangione, Pasquale B. Esposito et al. · 2013 · Nephrology Dialysis Transplantation
Review article: Risks of anemia and related management strategies: can perioperative blood management improve patient safety?
Gregory M. T. Hare, John J Freedman, C. David Mazer · 2013 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
Hemoglobin decline, function, and mortality in the elderly: The cardiovascular health study
Neil A. Zakai, Benjamin C. French, Alice M. Arnold, Anne B. Newman, Linda F. Fried, John A. Robbins, Paulo H. M. Chaves, Mary Cushman · 2012 · American Journal of Hematology
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease
Bhupesh Panwar, Orlando M. Gutiérrez · 2016 · Seminars in Nephrology
Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts
Peter Valent, Guntram Büsche, Igor Theurl, Iris Z. Uras, Ulrich Germing, Reinhard Stauder, Karl Sotlar, Wolfgang Füreder, Peter Bettelheim, Michael Pfeilstöcker et al. · 2018 · Haematologica
Anemia on Admission Predicts Short- and Long-Term Outcomes in Patients with Acute Ischemic Stroke
Haralampos J. Milionis, Vasileios Papavasileiou, Ashraf Eskandari, Suzette Rémillard, George Ntaios, Patrik Michel · 2014 · International Journal of Stroke
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)
John J.V. McMurray, Hajime Uno, Petr Jarolı́m, Akshay Suvas Desai, Dick de Zeeuw, Kai‐Uwe Eckardt, Peter T. Ivanovich, Andrew S. Levey, Eldrin Foster Lewis, Janet B. McGill et al. · 2011 · American Heart Journal
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, Michael Reusch, Toshihiro Misumi · 2019 · Advances in Therapy
Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Pablo E. Pérgola, Matt Devalaraja, Steven Fishbane, Michel Chonchol, Vandana S. Mathur, Mark T. Smith, Larry Lo, Kurt Herzog, Rahul K. Kakkar, Michael Davidson · 2020 · Journal of the American Society of Nephrology
Appraising Stroke Risk in Maintenance Hemodialysis Patients: A Large Single-Center Cohort Study
Albert John Power, Kakit Chan, Seema K. Singh, David H. Taube, Neill D. Duncan · 2011 · American Journal of Kidney Diseases
Microalbuminuria: target for renoprotective therapy PRO
Sara S. Roscioni, Hiddo J.L. Heerspink, Dick de Zeeuw · 2014 · Kidney International
Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease
Sundararaman Swaminathan, Sudhir V. Shah · 2011 · Kidney International
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy
Hiddo J.L. Heerspink, Dennis L. Andress, George L. Bakris, John J. Brennan, Ricardo Correa‐Rotter, Jyotirmoy Dey, Fan Fan Hou, Dalane W. Kitzman, Donald E. Kohan, Hirofumi Makino et al. · 2018 · Diabetes Obesity and Metabolism
Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review
Bruce Spinowitz, Roberto Pecoits‐Filho, Wolfgang C. Winkelmayer, Pablo E. Pérgola, Samuel Rochette, Philippe Thompson‐Leduc, Patrick Lefèbvre, Gigi Shafai, Ana Bozas, Myrlene Sanon et al. · 2019 · Journal of Medical Economics
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD
Geoffrey A. Block, Martha S. Block, Gerard Smits, Rupal C. Mehta, Tamara Isakova, Myles Selig Wolf, Glenn Matthew Chertow · 2019 · Journal of the American Society of Nephrology
Effects of recombinant human erythropoietin in normal humans
Carsten Lundby, Niels Vidiendal Olsen · 2010 · The Journal of Physiology
Drug Therapy in Patients With Chronic Renal Failure
Bertram Hartmann, David Czock, Frieder Keller · 2010 · Deutsches Ärzteblatt international
Neurological complications in chronic kidney disease patients
Jean‐Marc Chillon, Ziad A. Massy, Bénédicte Stengel · 2015 · Nephrology Dialysis Transplantation
Chronic kidney disease‐related physical frailty and cognitive impairment: a systemic review
Zhiyuan Shen, Qingwei Ruan, Zhuowei Yu, Zhongquan Sun · 2016 · Geriatrics and gerontology international/Geriatrics & gerontology international
Observational Studies Versus Randomized Controlled Trials: Avenues to Causal Inference in Nephrology
Csaba Pal Kovesdy, Kamyar Kalantar‐Zadeh · 2012 · Advances in Chronic Kidney Disease
Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis
David M. Charytan, Amy Barton Pai, Christopher T. Chan, Daniel W. Coyne, Adriana M. Hung, Csaba Pal Kovesdy, Steven N. Fishbane · 2014 · Journal of the American Society of Nephrology
Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD
Masaomi Nangaku, Kazuoki Kondo, Yoshimasa Kokado, Kiichiro Ueta, Genki Kaneko, Tsubasa Tandai, Yutaka Kawaguchi, Yasuhiro Komatsu · 2021 · Journal of the American Society of Nephrology
Platelet Abnormalities in CKD and Their Implications for Antiplatelet Therapy
Constance C. F. M. J. Baaten, Jonas R. Schröer, Jürgen Floege, Nikolaus Marx, Joachim Jankowski, Martin Berger, Heidi Noels · 2021 · Clinical Journal of the American Society of Nephrology
Molecular mechanisms of ischemic preconditioning in the kidney
Pinelopi P. Kapitsinou, Volker H. Haase · 2015 · American Journal of Physiology-Renal Physiology
Current Status of Pharmacologic Therapies in Patient Blood Management
Lawrence T. Goodnough, Aryeh Shander · 2012 · Anesthesia & Analgesia
Role of Artificial Intelligence in Kidney Disease
Qiongjing Yuan, Haixia Zhang, Tianci Deng, Shumei Tang, Xiangning Yuan, Wenbin Tang, Yanyun Xie, Huipeng Ge, Xiufen Wang, Qiaoling Zhou et al. · 2020 · International Journal of Medical Sciences
Efficacy and Cardiovascular Safety of Roxadustat in Dialysis-Dependent Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies
Jonathan Barratt, Władysław Sułowicz, Michael Schömig, Ciro Esposito, Michael Reusch, James Young, Botond Szabolcs Csiky · 2021 · Advances in Therapy
High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study
Frank Martinez, Nassim Kamar, Nicolas Pallet, Philippe Lang, Antoine Dürrbach, Yvon Lebranchu, A. Adem, S. Barbier, Élisabeth Cassuto, François Glowaki et al. · 2010 · American Journal of Transplantation
Effect of Red Cell Transfusions on Future Kidney Transplantation
Gregorio T. Obrador, Iain C. Macdougall · 2012 · Clinical Journal of the American Society of Nephrology
Long‐term efficacy and safety of hypoxia‐inducible factor prolyl hydroxylase inhibitors in anaemia of chronic kidney disease: A meta‐analysis including 13,146 patients
Huanhuan Chen, Qingfeng Cheng, Jiuxiang Wang, Xiaofang Zhao, Shenyin Zhu · 2021 · Journal of Clinical Pharmacy and Therapeutics
Neuropsychiatric complications of chronic kidney disease
Rory McQuillan, Sarbjit Vanita Jassal · 2010 · Nature Reviews Nephrology
Treatment of Anemia in Patients With Heart Disease
Devan L. Kansagara, Edward Dyer, Honora L. Englander, Rongwei F. Fu, Michele Freeman, David Kagen · 2013 · Annals of Internal Medicine
The iron cycle in chronic kidney disease (CKD): from genetics and experimental models to CKD patients
Kimberly B. Zumbrennen‐Bullough, Jodie L. Babitt · 2013 · Nephrology Dialysis Transplantation
Kidney disease as a determinant of cognitive decline and dementia
Thorleif Etgen · 2015 · Alzheimer s Research & Therapy
Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants with chronic kidney disease
Louis Holdstock, Borut Čižman, Amy M. Meadowcroft, Nandita Biswas, Brendan Mark Johnson, Delyth Jones, Sung Gyun Kim, Steven Zeig, John J. Lepore, Alexander R. Cobitz · 2018 · Clinical Kidney Journal
Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity
Chiara Cantarelli, Andrea Angeletti, Paolo Cravedi · 2019 · American Journal of Transplantation
Anemia and clinical outcomes in patients with non-dialysis dependent or dialysis dependent severe chronic kidney disease: a Danish population-based study
Gunnar Vase Toft, Uffe Heide‐Jørgensen, Heleen van Haalen, Glen James, Katarina Hedman, Henrik Birn, Christian Fynbo Christiansen, Reimar Wernich Thomsen · 2019 · Journal of Nephrology
Diastolic function is a strong predictor of mortality in patients with chronic kidney disease
Ahmad Farshid, Rajeev Kumar Pathak, Bruce Shadbolt, Leonard Arnolda, Girish Sricant Talaulikar · 2013 · BMC Nephrology
Comparison of rates of reported adverse events associated with i.v. iron products in the United States
George R. Bailie · 2012 · American Journal of Health-System Pharmacy
The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease
David Collister, Paul V. J. Komenda, Brett M. Hiebert, Ravindi Gunasekara, Yang Xu, Frederick Eng, Blake Lerner, Kerry Macdonald, Claudio Rigatto, Navdeep Tangri · 2016 · Annals of Internal Medicine
Erythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trials
Dipak Kotecha, Katherine Ngo, Julia AE Walters, Luís Manzano, Alberto Palazzuoli, Marcus D Flather · 2011 · American Heart Journal
Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease
Matthew J. Sheetz, Philip Barrington, Sophie Callies, Paul H. Berg, Juliet McColm, Thomas C Marbury, Brian Scott Decker, Gregory L. Dyas, Stephanie M.E. Truhlar, Robert J. Benschop et al. · 2019 · British Journal of Clinical Pharmacology
Safety of Intravenous Iron in Dialysis
Ingrid Hougen, David Collister, Mathieu Bourrier, Thomas W. Ferguson, Laura Hochheim, Paul V. J. Komenda, Claudio Rigatto, Navdeep Tangri · 2018 · Clinical Journal of the American Society of Nephrology
Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis
Qiyan Zheng, Huisheng Yang, Luying Sun, Ruojun Wei, Xinwen Fu, Ya‐Hui Wang, Yishan Huang, Yuning Liu, Wei Jing Liu · 2020 · Pharmacological Research
Randomized Trials Versus Common Sense and Clinical Observation
Alexander C. Fanaroff, Robert M. Califf, Robert A. Harrington, Christopher Bull Granger, John J.V. McMurray, Manesh R. Patel, Deepak L. Bhatt, Stephan Windecker, Adrian F. Hernandez, Charles Michael Gibson et al. · 2020 · Journal of the American College of Cardiology
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis
Shinji Tanaka, Didier Portilla, Mark Douglas Okusa · 2023 · Nature Reviews Nephrology
HIF prolyl hydroxylase inhibitors for anemia
Eugene Muchnik, Joshua Kaplan · 2011 · Expert Opinion on Investigational Drugs
Timing and Determinants of Erythropoietin Deficiency in Chronic Kidney Disease
Lucile Mercadal, Marie Metzger, Nicole Casadevall, Jean‐Philippe Haymann, Alexandre Karras, Jean‐Jacques Boffa, Martin Flamant, François Vrtovsnik, Bénédicte Stengel, Marc Froissart · 2011 · Clinical Journal of the American Society of Nephrology
Hemoglobin Concentration and Risk of Incident Stroke in Community-Living Adults
Bhupesh Panwar, Suzanne E. Judd, David G. Warnock, William M. McClellan, John N. Booth, Paul Muntner, Orlando M. Gutiérrez · 2016 · Stroke
Peritoneal Dialysis in Children
Bradley A. Warady, Steven R. Alexander, Franz S. Schaefer · 2009 · Springer eBooks
Can We Improve Quality of Life of Patients on Dialysis?
Bernard G. Jaar, Alex R. Chang, Laura Plantinga · 2013 · Clinical Journal of the American Society of Nephrology
A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial
Tadao Akizawa, Masaomi Nangaku, Takuhiro Yamaguchi, Masanobu Arai, Ryosuke Koretomo, Atsushi Matsui, Hideki Hirakata · 2019 · American Journal of Nephrology
Outcomes of Desidustat Treatment in People with Anemia and Chronic Kidney Disease: A Phase 2 Study
Deven V. Parmar, Kevinkumar Kansagra, Jatin C. Patel, Shuchi Joshi, Nitin Sharma Pradhi Srivastava Satish Kumar Gupta Anjana Sharma, Apeksha D. Shelat, Nirav Bipin Patel, Vishal B. Nakrani, Farheen Shaikh, Harilal Patel et al. · 2019 · American Journal of Nephrology
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD
Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, Yusuke Yamaguchi, Michael Reusch · 2021 · Kidney International Reports
Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD
Louise M. MOIST, Stéphan Troyanov, Colin Thomas White, Lori D Wazny, Jo-Anne S. Wilson, Phil McFarlane, Lori Harwood, Manish M. Sood, Steven Soroka, Adam Stuart Bass et al. · 2013 · American Journal of Kidney Diseases
Stroke in patients with chronic kidney disease…: How do we approach and manage it?
Shobhana Nayak‐Rao, M. Pradeep Shenoy · 2017 · Indian Journal of Nephrology
Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications
David S.H. Bell, Edison Gonçalves · 2019 · Diabetes Obesity and Metabolism
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
Volker H. Haase, Glenn Matthew Chertow, Geoffrey A. Block, Pablo E. Pérgola, Emil M. deGoma, Zeeshan Khawaja, Amit Kumar Sharma, Bradley J. Maroni, Peter Andrew McCullough · 2018 · Nephrology Dialysis Transplantation
Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis
Marie Evans, Hannah Bower, Elinor Cockburn, Stefan H. Jacobson, Peter F. Barany, Juan Jesús Carrero · 2020 · Clinical Kidney Journal
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
Jae Hyun Bae · 2025 · Diabetes & Metabolism Journal
Priming of hypoxia-inducible factor by neuronal nitric oxide synthase is essential for adaptive responses to severe anemia
Albert K.Y. Tsui, Philip A. Marsden, C. David Mazer, S. Lee Adamson, R. Mark Henkelman, J. J. David Ho, David Franklin Wilson, Scott Patrick Heximer, Kim Alexander Connelly, Steffen‐Sebastian Bolz et al. · 2011 · Proceedings of the National Academy of Sciences
Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients
Katherine Ngo, Dipak Kotecha, Julia AE Walters, Luís Manzano, Alberto Palazzuoli, Dirk Jan van Veldhuisen, Marcus D Flather · 2010 · Cochrane Database of Systematic Reviews
Early renin‐angiotensin system intervention is more beneficial than late intervention in delaying end‐stage renal disease in patients with type 2 diabetes
Bauke Schievink, Tobias F. Kröpelin, Skander Mulder, H.‐H. Parving, Giuseppe Remuzzi, Jamie P. Dwyer, Pepijn Vemer, Dick de Zeeuw, Hiddo J.L. Heerspink · 2015 · Diabetes Obesity and Metabolism
Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD
Junichi Hoshino, Daniel G. Muenz, Jarcy Zee, Nidhi Sukul, Élodie Speyer, Murilo Henrique Guedes, Antônio Alberto Lopes, Koichi Asahi, Heleen van Haalen, Glen James et al. · 2020 · Journal of Renal Nutrition
Anemia associated with chronic heart failure: current concepts
Anil Kumar Agarwal, Shah · 2013 · Clinical Interventions in Aging
Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States
Wendy L. St. Peter, Haifeng Guo, Shaum Kabadi, David T. Gilbertson, Yi Peng, Trudy B. Pendergraft, Suying Li · 2018 · BMC Nephrology
Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease
Ughetta del Balzo, Pierre E. Signore, Gail Walkinshaw, Todd W. Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael Arend, Lee A. Flippin, F. Aisha Chow et al. · 2020 · Journal of Pharmacology and Experimental Therapeutics
Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease
Eldrin Foster Lewis, Marc A. Pfeffer, Amy Feng, Hajime Uno, John J.V. McMurray, Robert Toto, Shravanthi R. Gandra, Scott David Solomon, Moustafa Moustafa, Iain C. Macdougall et al. · 2011 · Clinical Journal of the American Society of Nephrology
Safety concerns about intravenous iron therapy in patients with chronic kidney disease
Lucia Del Vecchio, Selena Longhi, Francesco Locatelli · 2016 · Clinical Kidney Journal